What does it take to work in partnership with the EORTC?
As an academic research organization, the EORTC adheres to Principles of Independence which include a peer review process, database control by academia, analysis of primary endpoints, publication of primary analysis, and controlled access to biological material.
This ensures the highest quality of research projects and provides additional level of scientific relevance vis à vis regulators and public visibility for changing practice clinical research.
Principles of Independence
- Peer review process / approval (Protocol Review Committee)
- Database control by academia (Independent Data Monitoring Committee)
- Analysis of primary endpoints
- Publication of primary analysis
- Controlled access to biological material
How does the EORTC budget its studies?
Three levels of studies
- Fully academic trails answer questions that are not necessarily of direct interest to the pharmaceutical industry. These trials are supported by charitable and/or public sources.
- Educational Grant trials aim to answer questions that are of potential interest to the pharmaceutical industry. These trials are partially supported by Pharma in the form of providing the trial drug(s) and/or compensation to the sites.
- Fully supported trials are registration trials, but the scientific value is independently confirmed. These trials are fully supported by Pharma.
Desired outcome of EORTC – Industry collaboration
- Improve treatments for patients with cancer in a challenging economic environment